Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.

Roczniki Akademii Medycznej w Białymstoku (1995)

Volumn 50, Issue , 2005, Pages 204-207

  Jablonska E ^a   Kiersnowska Rogowska, B ^a   Rogowski, F ^a   Parfienczyk A ^a   Puzewska, W ^a   Bukin, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; CYCLOPHOSPHAMIDE; DRUG DERIVATIVE; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; FLUDARABINE; MEMBRANE PROTEIN; MITOXANTRONE; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIDARABINE;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; SOLUBILITY;

ANTIGENS, CD95; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; CYCLOPHOSPHAMIDE; FAS LIGAND PROTEIN; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MITOXANTRONE; SOLUBILITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS; VIDARABINE;

EID: 33644823697     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)